Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes
Wednesday 12 March 2025, 12:55 AM
14 minutes to Read
Prescribing cannibinoid products
Sunday 1 July 2018, 12:00 PM
Regulating medicinal cannabis is difficult and complex
The prescribing and use of cannabis-based medicines is strictly regulated in New Zealand. University of Auckland pharmacy law lecturer Sanya Ram explores the current legal requirements for prescribing and dispensing cannabinoid products
The therapeutic potential for medicinal cannabis has been topical and has provoked much debate globally.
Regulating medicinal cannabis is difficul
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.
References
- Zolotov Y, Vulfsons S, Zarhin D, et al. Medical cannabis: An oxymoron? Physicians’ perceptions of medical cannabis. Int J Drug Policy 2018;57(7):4–10.
- Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA 2015;313(24):2456–73.
- Misuse of Drugs Act,1975 (NZ).
- Misuse of Drugs Regulations,1977 (NZ).
- Ministry of Health. CBD products. Available from: www.health.govt.nz (Accessed May, 2018).
- Ministry of Health. Prescribing cannabis based products. Available from: www.health. govt.nz (Accessed May, 2018).
- Misuse of Drugs Regulations,1977 (NZ), regulation 29 (1A).
- Medicines Act, 1981 (NZ), s29.
- Medsafe. Sativex oromucosal spray. Available from: www.medsafe.govt.nz (Accessed May 2018).
Educate archive
Class
Hosted Content 2
Why recognising the signs of dehydration is important...
Saturday 1 February 2025, 08:30 AM
2 minutes to Read
Latest issue
